Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis.

Zondag W, Kooiman J, Klok FA, Dekkers OM, Huisman MV.

Eur Respir J. 2013 Jul;42(1):134-44. doi: 10.1183/09031936.00093712. Epub 2012 Oct 25.

2.

Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis.

Piran S, Le Gal G, Wells PS, Gandara E, Righini M, Rodger MA, Carrier M.

Thromb Res. 2013 Nov;132(5):515-9. doi: 10.1016/j.thromres.2013.08.012. Epub 2013 Aug 28. Review.

PMID:
24035045
3.

Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review.

Janjua M, Badshah A, Matta F, Danescu LG, Yaekoub AY, Stein PD.

Thromb Haemost. 2008 Nov;100(5):756-61. Review.

PMID:
18989517
4.

Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review.

Squizzato A, Galli M, Dentali F, Ageno W.

Eur Respir J. 2009 May;33(5):1148-55. doi: 10.1183/09031936.00133608. Review.

5.

Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Vollenweider DJ, Jarrett H, Steurer-Stey CA, Garcia-Aymerich J, Puhan MA.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD010257. doi: 10.1002/14651858.CD010257. Review.

PMID:
23235687
6.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
7.

A review on state-of-the-art data regarding safe early discharge following admission for pulmonary embolism: what do we know?

Barra SN, Paiva L, Providência R, Fernandes A, Marques AL.

Clin Cardiol. 2013 Sep;36(9):507-15. doi: 10.1002/clc.22144. Epub 2013 May 29. Review.

8.
9.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
10.

Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.

Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ.

Crit Care Med. 2013 Sep;41(9):2088-98. doi: 10.1097/CCM.0b013e31828cf104. Review.

PMID:
23782973
11.

Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.

Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P.

J Intern Med. 2008 Jan;263(1):52-60. Review.

12.

Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review.

PMID:
22744711
13.

Management of venous thromboembolism: a systematic review for a practice guideline.

Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB.

Ann Intern Med. 2007 Feb 6;146(3):211-22. Epub 2007 Jan 29. Review. Erratum in: Ann Intern Med. 2007 Mar 6;146(5):396. Hoffman, Lawrence V [corrected to Hofmann, Lawrence V].

PMID:
17261856
14.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.

Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006649. doi: 10.1002/14651858.CD006649.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD006649.

PMID:
21491395
15.

[The optimal duration of anticoagulant treatment following pulmonary embolism].

Couturaud F.

Rev Mal Respir. 2011 Dec;28(10):1265-77. doi: 10.1016/j.rmr.2011.04.017. Epub 2011 Nov 3. Review. French.

PMID:
22152935
16.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
17.

Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline.

Lederle FA, Zylla D, MacDonald R, Wilt TJ.

Ann Intern Med. 2011 Nov 1;155(9):602-15. doi: 10.7326/0003-4819-155-9-201111010-00008. Review.

PMID:
22041949
18.

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

van Der Heijden JF, Hutten BA, Büller HR, Prins MH.

Cochrane Database Syst Rev. 2000;(4):CD002001. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002001.

PMID:
11034739
19.

Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA.

Ann Vasc Surg. 2013 Apr;27(3):355-69. doi: 10.1016/j.avsg.2012.06.010. Epub 2013 Jan 23. Review.

PMID:
23351997
20.

Can selected patients with newly diagnosed pulmonary embolism be safely treated without hospitalization? A systematic review.

Vinson DR, Zehtabchi S, Yealy DM.

Ann Emerg Med. 2012 Nov;60(5):651-662.e4. doi: 10.1016/j.annemergmed.2012.05.041. Epub 2012 Sep 1. Review. Erratum in: Ann Emerg Med. 2015 Feb;65(2):177.

PMID:
22944455

Supplemental Content

Support Center